Q4 FY2022 Revenue of $955.0 million vs. $894.3 million in Q4 last year, up 7% year-over-year (up 25% ex. revenue from ventilators) Earnings per share (EPS) of.
Q4 FY2022 Revenue of $955.0 million vs. $894.3 million in Q4 last year, up 7% year-over-year (up 25% ex. revenue from ventilators) Earnings per share (EPS) of.
Revenue of $848.7 million vs. $832.4 million in prior year EPS of $0.08 vs. $0.18 in prior year Adjusted EPS(1) of $0.19 vs. $0.22 ($0.19 excluding COVID-19.